OA09832A - Pharmaceutical composition for the treatment of protozoal diseases particularly of trypanosomiasis, comprising D-carnitrine or acyl derivative of D-carnitine. - Google Patents

Pharmaceutical composition for the treatment of protozoal diseases particularly of trypanosomiasis, comprising D-carnitrine or acyl derivative of D-carnitine.

Info

Publication number
OA09832A
OA09832A OA59786A OA59786A OA09832A OA 09832 A OA09832 A OA 09832A OA 59786 A OA59786 A OA 59786A OA 59786 A OA59786 A OA 59786A OA 09832 A OA09832 A OA 09832A
Authority
OA
OAPI
Prior art keywords
carnitrine
trypanosomiasis
carnitine
treatment
pharmaceutical composition
Prior art date
Application number
OA59786A
Inventor
Mario Manganaro
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Publication of OA09832A publication Critical patent/OA09832A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
OA59786A 1989-05-05 1990-05-04 Pharmaceutical composition for the treatment of protozoal diseases particularly of trypanosomiasis, comprising D-carnitrine or acyl derivative of D-carnitine. OA09832A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8947916A IT1231944B (en) 1989-05-05 1989-05-05 PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF PROTOZOOSIS, ESPECIALLY OF TRIPASONOMYASIS INCLUDING D-CARNITINE OR AN ALCANOYL DERIVATIVE OF D-CARNITINE

Publications (1)

Publication Number Publication Date
OA09832A true OA09832A (en) 1994-04-15

Family

ID=11263328

Family Applications (1)

Application Number Title Priority Date Filing Date
OA59786A OA09832A (en) 1989-05-05 1990-05-04 Pharmaceutical composition for the treatment of protozoal diseases particularly of trypanosomiasis, comprising D-carnitrine or acyl derivative of D-carnitine.

Country Status (5)

Country Link
AP (1) AP137A (en)
GB (1) GB2230953B (en)
IT (1) IT1231944B (en)
OA (1) OA09832A (en)
ZA (1) ZA903352B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1254136B (en) * 1992-01-16 1995-09-08 Sigma Tau Ind Farmaceuti ACIL CARNITINE ESTERS WITH LONG CHAIN ALIPHATIC ALCOHOLS AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM, WITH ANTI-Fungal activity.
IT1254135B (en) * 1992-01-16 1995-09-08 Sigma Tau Ind Farmaceuti ACIL CARNITINE ESTERS WITH LONG CHAIN ALIPHATIC ALCOHOLS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, WITH ANTIBACTERIAL ACTIVITY.

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5058213A (en) * 1973-09-26 1975-05-21
DE2903579A1 (en) * 1978-02-03 1979-08-09 Sigma Tau Ind Farmaceuti USE OF ACETYL CARNITINE AND OTHER ACYLDER DERIVATIVES OF CARNITINE FOR THE TREATMENT OF HYPERLIPOPROTEINEMIC AND HYPERLIMPIDAEMIA AND MEDICINAL PRODUCTS
DE2903558C2 (en) * 1978-02-03 1994-09-01 Sigma Tau Ind Farmaceuti Use of L-carnitine
IT1156769B (en) * 1978-05-25 1987-02-04 Sigma Tau Ind Farmaceuti THERAPEUTIC APPLICATION OF CARNITINE AND OTHER ACIL DERIVATIVES OF CARNITINE
IT1206954B (en) * 1979-02-12 1989-05-17 Sigma Tau Ind Farmaceuti THERAPEUTIC AGENTS BASED ON AN ACIL DERIVATIVE OF CARNITINE FOR THE TREATMENT OF PERIPHERAL VASCULOPATHIES
JPS5661314A (en) * 1979-10-24 1981-05-26 Otsuka Pharmaceut Factory Inc Preventive against side-effect for dialytic patient
JPS57126420A (en) * 1981-01-26 1982-08-06 Eiji Murakami Drug for digestive organ
IT1142934B (en) * 1981-11-06 1986-10-15 Sigma Tau Ind Farmaceuti USE OF CARNITINE AND LOWER ACILCARNITINES IN THE THERAPEUTIC TREATMENT OF VEIN PATHOLOGY
IT1191945B (en) * 1986-06-04 1988-03-31 Avantgarde Spa N-ALCHYLAMIDS OF D (+) - CARNITINE EQUIPPED WITH ANTIBACTERIAL ACTIVITY, PROCEDURE FOR THEIR PREPARATION AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING THEM
CH676930A5 (en) * 1988-05-26 1991-03-28 Bernardini Attilio

Also Published As

Publication number Publication date
ZA903352B (en) 1991-02-27
IT8947916A0 (en) 1989-05-05
AP9000180A0 (en) 1990-07-31
IT1231944B (en) 1992-01-16
GB9010190D0 (en) 1990-06-27
GB2230953A (en) 1990-11-07
GB2230953B (en) 1993-03-24
AP137A (en) 1991-08-05

Similar Documents

Publication Publication Date Title
EP0427588A3 (en) System for the administration of sterile liquids, especially pharmaceutical, nutritive or energetic
ES511433A0 (en) "PROCEDURE FOR THE PREPARATION OF USEFUL PRODUCTS, PARTICULARLY IN MEDICINES USABLE FOR THE TREATMENT OF MELANOMAS".
AU4048295A (en) Peptide medicaments for the treatment of disease
KR920701466A (en) Pharmaceutical products for the treatment of immunomodulatory disorders
GR3004150T3 (en) Medicaments for the treatment or prevention of the withdrawal syndrome.
LTIP863A (en) Aminobenzodiazepines, process for preparing thereof and application for the treatment and prevention of viral diseases
ZA9110018B (en) 2-acylamido derivatives of 3,4-dihydro-3-oxo-quinoxaline having pharmaceutical activity.
IL90551A (en) Stable, injectable, aqueous pharmaceutical compositions for the treatment of cardiac conditions
AU9173191A (en) Medicaments for the treatment of papillomavirus diseases
AU550675B2 (en) Pharmaceutical compositions for the treatment of skin
EP0592903A3 (en) Use of ancrod for the preparation of drugs for the treatment of restenosis.
IT1210935B (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF CARDIOVASCULAR DISEASES.
NO913117D0 (en) PROCEDURE FOR THE TREATMENT OF NECESSARY DISEASES.
ZA929879B (en) Compositions for the treatment of mammalian diseases.
GB9103278D0 (en) Drug for the treatment of dermatitis
AU7950382A (en) Aromatic amino keto esters, pharmaceutical use
OA09832A (en) Pharmaceutical composition for the treatment of protozoal diseases particularly of trypanosomiasis, comprising D-carnitrine or acyl derivative of D-carnitine.
IL93242A0 (en) Pharmaceutical preparation for the treatment of tonsillitis
MA22880A1 (en) PROCESS FOR THE PREPARATION OF PHARMACEUTICAL PRODUCTS.
EP0421216A3 (en) Process for the preparation of 2,4, resp. 2,6 dihalo-aniline
IL96455A0 (en) Pharmaceutical compositions for the treatment of hsv
IL99666A0 (en) Pharmaceutical compositions for the treatment of diabetes
FR2690152B1 (en) PROCESS FOR THE PREPARATION AND TREATMENT OF PROPELLANTS.
ZA822176B (en) Pharmaceutical compositions for the treatment of diabetes
ZA877303B (en) Pharmaceutical composition for the treatment of high blood pressure